Epithelial ovarian tumors diagnostic study of choice: Difference between revisions

	Epithelial ovarian tumors Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Epithelial Ovarian Tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Epithelial ovarian tumors diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Epithelial ovarian tumors diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Epithelial ovarian tumors diagnostic study of choice
CDC on Epithelial ovarian tumors diagnostic study of choice
Epithelial ovarian tumors diagnostic study of choice in the news
Blogs on Epithelial ovarian tumors diagnostic study of choice
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Epithelial ovarian tumors diagnostic study of choice

VisualWikitext

Latest revision as of 13:46, 2 April 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]

Overview

Histology of the excised tumor after surgery is the gold standard test for the diagnosis of ovarian tumors. Surgery must be performed when the patient presents with an adnexal mass in the abdominal/pelvic exam and elevated serum concentration of associated tumor markers. Some may be diagnosed using ultrasonographic imaging. However, the tumor should be removed surgically.

Diagnostic Study of Choice

Histology of the excised tumor after surgery is the gold standard test for the diagnosis of ovarian epthelial tumors.^[1]^[2]

Surgery must be performed when:
- The patient presents with an adnexal mass in the abdominal/pelvic exam, and elevated serum concentration of hCG, LDH, AFP, and other associated tumor markers.
- The tumor should be removed surgically.

Epithelial ovarian tumor

Prior surgery

Initial surgery

Complete staging

Incomplete staging

Fertility sparing prefered

Fertility sparing not prefered

Treatment based
on
the staging

Imaging:
Chest/
abdomen/
pelvis CT with contrast

Fertility sparing surgery
and
complete staging

Surgery to stage

Treatment based on the staging and pathology of tumor

References

↑ Pectasides, D.; Pectasides, E.; Kassanos, D. (2008). "Germ cell tumors of the ovary". Cancer Treatment Reviews. 34 (5): 427–441. doi:10.1016/j.ctrv.2008.02.002. ISSN 0305-7372.
↑ Low, Jeffrey J.H.; Ilancheran, Arunachalam; Ng, Joseph S. (2012). "Malignant ovarian germ-cell tumours". Best Practice & Research Clinical Obstetrics & Gynaecology. 26 (3): 347–355. doi:10.1016/j.bpobgyn.2012.01.002. ISSN 1521-6934.

Template:WH Template:WS

Template:WikiDoc Sources

[PectasidesPectasides2008-1] Pectasides, D.; Pectasides, E.; Kassanos, D. (2008). "Germ cell tumors of the ovary". Cancer Treatment Reviews. 34 (5): 427–441. doi:10.1016/j.ctrv.2008.02.002. ISSN 0305-7372.

[LowIlancheran2012-2] Low, Jeffrey J.H.; Ilancheran, Arunachalam; Ng, Joseph S. (2012). "Malignant ovarian germ-cell tumours". Best Practice & Research Clinical Obstetrics & Gynaecology. 26 (3): 347–355. doi:10.1016/j.bpobgyn.2012.01.002. ISSN 1521-6934.

[1]

[2]

@@ Line 1: / Line 1: @@
-_NOTOC__
+{{Epithelial ovarian tumors}}
-{{Ovarian germ cell tumor}}
 {{CMG}}; {{AE}} {{HMHJ}}
 == Overview ==
-[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] [[germ cell]] [[Tumor|tumors]]. [[Surgery]] must be performed when the patient presents with an [[adnexal]] [[mass]] in the [[abdominal]]/[[pelvic]] [[Physical examination|exam]] and elevated serum concentration of associated [[tumor markers]]. [[Mature cystic teratoma|Mature teratoma]] may be [[Diagnosis|diagnosed]] using [[Ultrasound|ultrasonographic imaging]]. However, the [[tumor]] should be removed [[Surgery|surgically]].
+[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] [[Tumor|tumors]]. [[Surgery]] must be performed when the patient presents with an [[adnexal]] [[mass]] in the [[abdominal]]/[[pelvic]] [[Physical examination|exam]] and elevated serum concentration of associated [[tumor markers]]. Some may be [[Diagnosis|diagnosed]] using [[Ultrasound|ultrasonographic imaging]]. However, the [[tumor]] should be removed [[Surgery|surgically]].
 == Diagnostic Study of Choice ==
-[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] [[germ cell]] [[tumors]].<ref name="PectasidesPectasides2008">{{cite journal|last1=Pectasides|first1=D.|last2=Pectasides|first2=E.|last3=Kassanos|first3=D.|title=Germ cell tumors of the ovary|journal=Cancer Treatment Reviews|volume=34|issue=5|year=2008|pages=427–441|issn=03057372|doi=10.1016/j.ctrv.2008.02.002}}</ref><ref name="LowIlancheran2012">{{cite journal|last1=Low|first1=Jeffrey J.H.|last2=Ilancheran|first2=Arunachalam|last3=Ng|first3=Joseph S.|title=Malignant ovarian germ-cell tumours|journal=Best Practice & Research Clinical Obstetrics & Gynaecology|volume=26|issue=3|year=2012|pages=347–355|issn=15216934|doi=10.1016/j.bpobgyn.2012.01.002}}</ref>
+[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] epthelial [[tumors]].<ref name="PectasidesPectasides2008">{{cite journal|last1=Pectasides|first1=D.|last2=Pectasides|first2=E.|last3=Kassanos|first3=D.|title=Germ cell tumors of the ovary|journal=Cancer Treatment Reviews|volume=34|issue=5|year=2008|pages=427–441|issn=03057372|doi=10.1016/j.ctrv.2008.02.002}}</ref><ref name="LowIlancheran2012">{{cite journal|last1=Low|first1=Jeffrey J.H.|last2=Ilancheran|first2=Arunachalam|last3=Ng|first3=Joseph S.|title=Malignant ovarian germ-cell tumours|journal=Best Practice & Research Clinical Obstetrics & Gynaecology|volume=26|issue=3|year=2012|pages=347–355|issn=15216934|doi=10.1016/j.bpobgyn.2012.01.002}}</ref>
 * [[Surgery]] must be performed when:
 ** The patient presents with an [[adnexal]] [[mass]] in the [[abdominal]]/[[pelvic]] exam, and elevated serum concentration of [[Human chorionic gonadotropin|hCG]], [[Lactate dehydrogenase|LDH]], [[AFP]], and other associated [[tumor markers]].
-** [[Mature cystic teratoma|Mature teratoma]] may be [[Diagnose|diagnosed]] using [[Ultrasound imaging|ultrasonographic imaging]]. However, the [[tumor]] should be removed [[Surgery|surgically]].
+** The [[tumor]] should be removed [[Surgery|surgically]].
 {{familytree/start |summary=PE diagnosis Algorithm.}}
-{{familytree | | | | | | | | | | A02 | | | | | |A02=[[Malignant]] [[germ cell]] [[tumor]]}}
+{{familytree | | | | | | | | | | A02 | | | | | |A02=Epithelial ovarian [[tumor]]}}
 {{familytree | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | }}
 {{familytree | | | C01 | | | | | | | | | | | | | C02 | | |C01=Prior [[surgery]]|C02=Initial [[surgery]]}}
@@ Line 20: / Line 19: @@
 {{familytree | |!| | | |!| | | | | | | | | | |!| | | |!| | }}
 {{familytree | E01 | | E02 | | | | | | | | | E03 | | E04 |E01=Treatment based<br>on<br>the staging|E02=[[Imaging]]:<br>[[Chest]]/<br>[[abdomen]]/<br>[[pelvis]] [[CT]] with [[contrast]]|E03=[[Fertility]] sparing [[surgery]]<br>and<br>complete staging|E04=[[Surgery]] to stage}}
-{{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }}
+{{familytree | | | | | | | | | | | | | | | | |!| | | |!| | | | }}
-{{familytree | | | | | |!| | | | | | | | | | |`| F02 |'| | | |F02=Treatment based on the staging and [[pathology]] of [[tumor]]}}
+{{familytree | | | | | | | | | | | | | | | | |`| F02 |'| | | |F02=Treatment based on the staging and [[pathology]] of [[tumor]]}}
-{{familytree | | | |,|-|^|-|-|-|-|-|-|-|.| | | | | | | }}
-{{familytree | | | G01 | | | | | | | | G02 | | | | | | | | | | | | | | |G01=[[Yolk sac tumor]]<br>grade2-3 immature [[teratoma]],<br>non-gestational [[choriocarcinoma]]<br>or mixed [[histology]]|G02=[[Dysgerminoma]]<br>or<br>grade 1 immature [[teratoma]]|L03=[[Dysgerminoma]] or grade 1 immature [[teratoma]]}}
-{{familytree | | | |!| | | | | | | | | |!| | | | | | | | | | | | }}
-{{familytree | | | |!| | | | | |,|-|-|-|+|-|-|-|.|}}
-{{familytree | | | |!| | | | | I02 | | I03 | | I04 | |I02=[[Imaging]] and [[tumor markers]]<br>are<br>positive|I03=Negative [[imaging]]<br>and<br>positive [[tumor markers]]|I04=Negative [[imaging]]<br>and<br>negative or positive [[tumor markers]]}}
-{{familytree | | | |!| | | | | |!| | | |!| | | |!| | | |}}
-{{familytree | |,|-|^|-|.| | | K03 | | K04 | | K05 | | |K03=Decide according to [[fertility]] sparing preference<br>and/or [[pathologic]] finding<br>for [[surgery]] and<br>further [[adjuant therapy]]|K04=Observe|K05=Observe|}}
-{{familytree | J01 | | J02 | | | | | | | | | | | | | | | | | | |J01=[[Imaging]] and [[tumor markers]]<br>are<br>positive|J02=Negative [[imaging]]<br>and<br>negative and positive [[tumor markers]]}}
-{{familytree | |!| | | | | | | | | | | | | | | | | | | | | |}}
-{{familytree | K01 | | | | | | | | | | | | | | | | | | | |K01=Decide<br>according to<br>[[fertility]] sparing preference<br>for [[surgery]] and further [[chemotherapy]]|}}
-{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}}
 {{familytree | | | | | | | | | | | | | | | | | | | | | | | |}}
 {{familytree/end}}

Epithelial ovarian tumors diagnostic study of choice: Difference between revisions

Latest revision as of 13:46, 2 April 2019

Overview

Diagnostic Study of Choice

References

Navigation menu